.FDA declines psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Accept MDMA Treatment, Finding Additional Study The Nyc TimesFDA Turns Down Ecstasy-Based Drug The Commercial JournalFDA rejects to authorize novel MDMA therapy to alleviate post-traumatic stress disorder, with ask for additional trial data CNNFDA refuses initially experimental to handle PTSD, asking for even more study The Washington Article.